2.Effect of Ginseng Saponin on Human Chondrocyte.
Jin Hyung SUNG ; Jae Duk RYU ; Hyung Gyun JUNG ; Jin Young KIM
The Journal of the Korean Orthopaedic Association 1998;33(7):1921-1927
Earlier work suggested that Ginseng saponin had an effect on osteoblast and other cells, but there has been no report on saponin effects on chondrocyte. The purpose of this study was to investigate the effect of saponin on cultured human chondrocyte. The chondrocyte was isolated from human articular cartilage of knee joint during notchplasty of ACL reconstructive procedure using collagenase, and cultured in standard medium and serum free deficient medium, with addition of saponin(0(control), 10, 20, 50 microgram/ml concentration). DNA, RNA synthesis of chondrocyte was estimated on 36 hours and 5 days of culture by measuring of thymidine and uridine uptake. Human collagen type I and II synthesis was estimated by reverse transcriptation-polymerase chain reaction on 36 hours of culture. Low dose saponin was found to enhance DNA, RNA, and collagen synthesis of chondrocytes which were cultured with a deficient medium in comparison to the controls. It promoted cell proliferation of the osteoblasts cultured with a deficient medium in comparison to the controls. But, high dose saponin was found to diminish the synthesis of DNA, RNA and collagen. In summary, the results showed that the saponin increased proliferation and differentiation of the chondrocyte cultured in deficient medium. Therefore saponin seemed to act as a physiologic stimulant on human chondrocyte. But further study should be done.
Cartilage, Articular
;
Cell Proliferation
;
Chondrocytes*
;
Collagen
;
Collagen Type I
;
Collagenases
;
DNA
;
Humans*
;
Knee Joint
;
Osteoblasts
;
Panax*
;
RNA
;
Saponins*
;
Thymidine
;
Uridine
3.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
4.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
5.A Case of Intravascular Papillary Endothelial Hyperplasia with Angioleiomyoma.
Yong Gwan BAIK ; Hyung Jin KIM ; Ho Gyun LEE ; Jong Min KIM
Korean Journal of Dermatology 1997;35(1):155-159
Intravascular papillary endothelial hyperplasia is a relatively rare benign tumor, which is charaterized by the development of endothelial-lined papillary projections in a vascular lumen. They can occur as a pure form in which endothelial proliferation developes in a dilated vessel, a mixed form in which endothelial proliferation occurs within a pre-existing angioma. We herein report a case of intravascular papillary endothelial hyperplasia coexistent with angioleiomyoma occuring in a 54-year-old man, who had a slowly growing tumor on the right sole for 2 years. The histologic findings revealed a solitary encapsulated mass composed of smooth muscles and blood vessels in deep dermis and papillary endothelial hyperplasia in a neighboring blood vessel.
Angiomyoma*
;
Blood Vessels
;
Dermis
;
Hemangioma
;
Humans
;
Hyperplasia*
;
Middle Aged
;
Muscle, Smooth
6.Annular Erythema of Infancy.
Eui Hyun OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(8):667-668
No abstract available.
Erythema*
7.Cellular Consideration of Bladder Outlet Obstruction: The Prostate.
Journal of the Korean Continence Society 2002;6(1):1-7
No abstract available.
Prostate*
;
Urinary Bladder Neck Obstruction*
8.A Study on the CD34 Expression of Cutaneous Benign and Malignant Vascular Tumors.
Yong Kwan BAIK ; Hyung Geun MIN ; Ho Gyun LEE ; Jong Min KIM ; Jin Hee SOHN
Korean Journal of Dermatology 1998;36(5):759-764
BACKGROUND: CD34 is a 115 kD glycoprotein which is expressed on hematopoietic progenitor cells. It is also known as an immunohistochemical marker of endothelial cells. OBJECTIVE: This study was designed to investigate the patterns of CD34 expression on: (1) cutaneous benign and malignant vascular tumors and (2) on the mature and immature vessels of pyogenic grauloma and capillary hemangioma. METHOD: We performed immunoperoxidase staining using a monoclonal anti-CD34 antibody (QBEND/10) on formalin fixed, paraffin-embedded sections of 23 benign and malignant cutaneous vascular tumors. RESULTS: The results are summerized as follows: 1. In 3 cases of nevus flammeus and 6 cases of carvernous hemangioma, vascular endothelial cells of all hemangiomas showed CD34 expressions. In 5 cases of angiokeratoma, endothelial cells of hemangioma, did not express CD34. 2. In all 5 cases of pyogenic granulomas and one case of capillary hemangioma, endothelial cells of mature vessels, endothelial cells near the well-formed lumina and endothelial cells showing intracellular lumina showed strong positivity for CD34, wbile endothelial cells far from the lumina and endothelial cells without lumina formation mostly showed negative staining for CD34. 3. One cese of Kaposis sarcoma showed focall positivity for CD34 both in endothelial cells of the small, well-formed vessels and spindle cells. Two cases of angiosarcoma showed CD34 expression only in endothelial cells of well-formed, normal appearing vessels, whereas atypical endothelial cells of tumor vessels and spindle cells were negative for CD34. CONCLUSION: CD34 could be a marker for endothelium in mature, well-differentiated vascular structures and may serve as a marker of lumen formation or differentiation of endothelial cells.
Angiokeratoma
;
Endothelial Cells
;
Endothelium
;
Formaldehyde
;
Glycoproteins
;
Granuloma, Pyogenic
;
Hemangioma
;
Hemangioma, Capillary
;
Hemangiosarcoma
;
Hematopoietic Stem Cells
;
Negative Staining
;
Port-Wine Stain
;
Sarcoma, Kaposi
9.A case of Epididymal Cavernous Lymphangioma.
Tag Keun YOO ; Do Yeon CHOI ; Seok KIM ; Yong Taek ROH ; Hyung Gyun KIM ; Jong Wook LEE ; Jong Eun JOO
Korean Journal of Urology 2000;41(3):454-455
No abstract available.
Lymphangioma*
10.Transurethral Prostatectomy with Advanced Technique and Instruments.
Tag Keun YOO ; Seok KIM ; Yong Taek ROH ; Hyung Gyun KIM
Korean Journal of Andrology 1999;17(2):121-125
PURPOSE: We studied the therapeutic effect and safety of transurethral prostatectomy (TURP) performed with improved instruments by a moderately experienced resectionist. PATIENTS AND METHODS: Clinical data of the 95 consecutive patients who underwent TURP by one surgeon from March 1995 to June 1997 were analyzed. During this period, a continuous-irrigation 26F TUR sheath with a 30-degree lens attached to a monitor screen was used in most patients. RESULTS: The average weight of the resected adenoma was 10.8 7.4 gm, and the resection time was 47.2 21.2 minutes. The average weight of tissue resected per minute was 0.23 0.13 gm. Six patients required transfusion, and four suffered operative complications (one bladder perforation, one bladder neck injury, and two urethral injuries that enforced prolonged catheterization). Postoperative complications developed in seven cases. The duration of postoperative urethral catheterization averaged 2.8 days. The maximal flow rate was improved from 11.3 mL/sec to 20.6 mL/sec. Subjective satisfaction was mentioned by 95.6% of patients (91/95). In comparison with data from the first authors former report, all differences in terms of resection speed, safety, and morbidity were statistically significant. The therapeutic efficacy of the operation with the new equipment seems to be superior to that of other less invasive procedures, and even in terms of complications and duration of catheterization, these results are comparable to those of other procedures. CONCLUSIONS: We think that TURP deserves to be the primary treatment modality for the patients with benign prostatic hyperplasia who need surgical therapy if the procedure is performed by a properly trained surgeon equipped with modern TUR instruments.
Adenoma
;
Catheterization
;
Catheters
;
Humans
;
Neck Injuries
;
Postoperative Complications
;
Prostatic Hyperplasia
;
Transurethral Resection of Prostate*
;
Urinary Bladder
;
Urinary Catheterization
;
Urinary Catheters